https://www.taxtmi.com/caselaws?id=87108 The appeals concerning the interpretation of proviso (ii) to Section 4(1)(a) and the impact of exemption Notification on the assessable value of medicines under the Drug (Price Control) Order were dismissed. The Tribunal affirmed the Collector (Appeals)' decision, clarifying that the exemption Notification could not override the main Section. The manufacturer had the choice to avail the exemption or calculate the assessable value based on wholesale prices. The conflict was between the Section and the exemption Notification, not the proviso. Any consequential benefit for the respondent would be governed by the provisions of Section 11B of the Act. en-us Fri, 29 Aug 1997 00:00:00 +0530 Fri, 02 Sep 2011 17:57:20 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=87108 The appeals concerning the interpretation of proviso (ii) to Section 4(1)(a) and the impact of exemption Notification on the assessable value of medicines under the Drug (Price Control) Order were dismissed. The Tribunal affirmed the Collector (Appeals)' decision, clarifying that the exemption Notification could not override the main Section. The manufacturer had the choice to avail the exemption or calculate the assessable value based on wholesale prices. The conflict was between the Section and the exemption Notification, not the proviso. Any consequential benefit for the respondent would be governed by the provisions of Section 11B of the Act. Case-Laws Central Excise Fri, 29 Aug 1997 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=87108